Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo News· 9 hours agoSanofi and partner Regeneron’s blockbuster drug Dupixent was approved for a new indication — chronic...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo News· 5 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...